Trial Profile
An Open Label Randomised Comparative Trial to Establish the Efficacy of 3 mg/kg ArTiMist When Compared to Intravenous Quinine in Children With Severe or Complicated Falciparum Malaria, or Uncomplicated Falciparum Malaria With Gastrointestinal Complications
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2018
Price :
$35
*
At a glance
- Drugs Artemether (Primary) ; Quinine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors ProtoPharma
- 29 Apr 2014 New trial record